Establishment Labs Holdings Inc. (ESTA) stock
ESTANasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
$69.51−0.31 (-0.44%)
Close on Nov 17, 2026Market cap $2.07BP/E –Yield –
Establishment Labs total assets
Total assets on the balance sheet at the end of each period.
Establishment Labs's total assets was $358.88M at Sep 30, 2026. For fiscal 2025 it was $357.17M, up 3.0% from the year before. The highest annual figure on record is $357.17M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $357.17M | +3.0% |
| FY2024 | Dec 31, 2024 | $346.83M | +29.1% |
| FY2023 | Dec 31, 2023 | $268.64M | +27.3% |
| FY2022 | Dec 31, 2022 | $211.06M | +51.3% |
| FY2021 | Dec 31, 2021 | $139.53M | -10.8% |
| FY2020 | Dec 31, 2020 | $156.39M | +34.2% |
| FY2019 | Dec 31, 2019 | $116.53M | -0.0% |
| FY2018 | Dec 31, 2018 | $116.57M | +104.2% |
| FY2017 | Dec 31, 2017 | $57.10M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $358.88M | +5.9% |
| Q2 FY2026 | Jun 30, 2026 | $351.93M | +6.8% |
| Q1 FY2026 | Mar 31, 2026 | $351.04M | +5.3% |
| Q4 FY2025 | Dec 31, 2025 | $357.17M | +3.0% |
| Q3 FY2025 | Sep 30, 2025 | $338.90M | +19.9% |
| Q2 FY2025 | Jun 30, 2025 | $329.67M | +15.6% |
| Q1 FY2025 | Mar 31, 2025 | $333.36M | +10.4% |
| Q4 FY2024 | Dec 31, 2024 | $346.83M | +29.1% |
| Q3 FY2024 | Sep 30, 2024 | $282.69M | +4.5% |
| Q2 FY2024 | Jun 30, 2024 | $285.09M | -0.1% |
| Q1 FY2024 | Mar 31, 2024 | $301.84M | +44.2% |
| Q4 FY2023 | Dec 31, 2023 | $268.64M | +27.3% |
| Q3 FY2023 | Sep 30, 2023 | $270.53M | +44.2% |
| Q2 FY2023 | Jun 30, 2023 | $285.30M | +42.7% |
| Q1 FY2023 | Mar 31, 2023 | $209.36M | +47.9% |
| Q4 FY2022 | Dec 31, 2022 | $211.06M | +51.3% |
| Q3 FY2022 | Sep 30, 2022 | $187.65M | +26.5% |
| Q2 FY2022 | Jun 30, 2022 | $199.88M | +31.4% |
| Q1 FY2022 | Mar 31, 2022 | $141.56M | -7.1% |
| Q4 FY2021 | Dec 31, 2021 | $139.53M | -10.8% |
| Q3 FY2021 | Sep 30, 2021 | $148.36M | -4.1% |
| Q2 FY2021 | Jun 30, 2021 | $152.12M | -3.0% |
| Q1 FY2021 | Mar 31, 2021 | $152.35M | -9.5% |
| Q4 FY2020 | Dec 31, 2020 | $156.39M | +34.2% |
| Q3 FY2020 | Sep 30, 2020 | $154.68M | +30.8% |
| Q2 FY2020 | Jun 30, 2020 | $156.81M | +49.6% |
| Q1 FY2020 | Mar 31, 2020 | $168.42M | +54.6% |
| Q4 FY2019 | Dec 31, 2019 | $116.53M | -0.0% |
| Q3 FY2019 | Sep 30, 2019 | $118.26M | -2.6% |
| Q2 FY2019 | Jun 30, 2019 | $104.80M | +65.5% |
| Q1 FY2019 | Mar 31, 2019 | $108.96M | +90.8% |
| Q4 FY2018 | Dec 31, 2018 | $116.57M | – |
| Q3 FY2018 | Sep 30, 2018 | $121.47M | – |
| Q2 FY2018 | Jun 30, 2018 | $63.32M | – |
| Q4 FY2017 | Dec 31, 2017 | $57.10M | – |
See a number that looks wrong?